Literature DB >> 20101034

Sociodemographic differences in antiepileptic drug prescriptions to adult epilepsy patients.

P Mattsson1, T Tomson, O Eriksson, L Brännström, G Ringbäck Weitoft.   

Abstract

BACKGROUND: According to the Swedish Health Care Act, patients should be provided with the health care they need, regardless of sociodemographic status. We investigated whether in Sweden sociodemographic differences are associated with access to expert health care and antiepileptic drug (AED) prescriptions in epilepsy.
METHOD: Patients with epilepsy were identified in the National Patient Register. Persons >or=18 years on continuous AED treatment in 2006 were identified in the recently established Swedish Prescribed Drug Register. Data on sociodemographic variables were obtained from several other national registers. We linked data to examine whether epilepsy patients' access to neurologists and the prescription of individual AEDs are related to sex, age, educational level, area of residence, region of birth, or income. We also assessed whether AEDs are prescribed differently to patients with epilepsy by neurologists as compared to non-neurologists.
RESULTS: We identified 26,124 epilepsy patients in the register who were on continuous AED treatment (effective sample). Being women, young, highly educated, having high incomes, and residing in a larger city meant being more often treated by a neurologist than by other specialists. The prescriptions of AEDs differed according to gender, age, education, place of residence, and income. Lamotrigine and levetiracetam were prescribed to a larger extent by a neurologist rather than by other specialists.
CONCLUSIONS: This nationwide cross-sectional study of epilepsy patients indicates that sociodemographic characteristics are important for access to neurologists and prescriptions of individual antiepileptic drugs. Prospective studies using patient-related outcomes are needed to analyze the consequences of these differences.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20101034     DOI: 10.1212/WNL.0b013e3181cbcd5c

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  16 in total

1.  Antiepileptic drug use in community-dwelling and institutionalized elderly: a nationwide study of over 1,300,000 older people.

Authors:  Kristina Johnell; Johan Fastbom
Journal:  Eur J Clin Pharmacol       Date:  2011-04-28       Impact factor: 2.953

2.  Familial Liability to Epilepsy and Attention-Deficit/Hyperactivity Disorder: A Nationwide Cohort Study.

Authors:  Isabell Brikell; Laura Ghirardi; Brian M D'Onofrio; David W Dunn; Catarina Almqvist; Søren Dalsgaard; Ralf Kuja-Halkola; Henrik Larsson
Journal:  Biol Psychiatry       Date:  2017-08-12       Impact factor: 13.382

3.  Epilepsy, antiepileptic drugs, and serious transport accidents: A nationwide cohort study.

Authors:  Heléne E K Sundelin; Zheng Chang; Henrik Larsson; Paul Lichtenstein; Catarina Almqvist; Torbjörn Tomson; Jonas F Ludvigsson
Journal:  Neurology       Date:  2018-02-28       Impact factor: 9.910

4.  Autism and epilepsy: A population-based nationwide cohort study.

Authors:  Heléne E K Sundelin; Henrik Larsson; Paul Lichtenstein; Catarina Almqvist; Christina M Hultman; Torbjörn Tomson; Jonas F Ludvigsson
Journal:  Neurology       Date:  2016-06-15       Impact factor: 9.910

5.  Indications of newer and older anti-epileptic drug use: findings from a southern Italian general practice setting from 2005-2011.

Authors:  Domenico Italiano; Annalisa Capuano; Angela Alibrandi; Rosarita Ferrara; Angelo Cannata; Gianluca Trifirò; Janet Sultana; Carmen Ferrajolo; Michele Tari; Daniele Ugo Tari; Margherita Perrotta; Claudia Pagliaro; Concita Rafaniello; Edoardo Spina; Vincenzo Arcoraci
Journal:  Br J Clin Pharmacol       Date:  2015-06       Impact factor: 4.335

6.  Sociodemographic disparities in administration of antiepileptic drugs to adults with epilepsy in Germany: a retrospective, database study of drug prescriptions.

Authors:  Hajo M Hamer; Karel Kostev
Journal:  CNS Drugs       Date:  2014-08       Impact factor: 5.749

7.  Medication treatment for attention-deficit/hyperactivity disorder and the risk of acute seizures in individuals with epilepsy.

Authors:  Isabell Brikell; Qi Chen; Ralf Kuja-Halkola; Brian M D'Onofrio; Kelsey K Wiggs; Paul Lichtenstein; Catarina Almqvist; Patrick D Quinn; Zheng Chang; Henrik Larsson
Journal:  Epilepsia       Date:  2019-01-25       Impact factor: 5.864

8.  Association between poststroke epilepsy and death: A nationwide cohort study.

Authors:  Johan Zelano; Petra Redfors; Signild Åsberg; Eva Kumlien
Journal:  Eur Stroke J       Date:  2016-09-08

9.  Sociodemographic differences in medication use, health-care contacts and sickness absence among individuals with medication-overuse headache.

Authors:  Pernilla Jonsson; Mattias Linde; Gunnel Hensing; Tove Hedenrud
Journal:  J Headache Pain       Date:  2012-03-17       Impact factor: 7.277

10.  Sociodemographic factors associated with the first administration of anti-seizure medication in patients with focal epilepsy in Western China.

Authors:  Qiong Zhu; Yi Guo; Shuai Ma; Lili Yang; Zhonghua Lin; Hongbin Sun; Guangzong Li; Liang Yu
Journal:  BMC Neurol       Date:  2021-06-29       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.